Loading company details...
Latest Form 4 (Oct 1, 2026): Eyal Talor (Chief Scientific Officer): Grant/Award of 1,165 shares, $2.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Eyal Talor, Chief Scientific Officer | Grant/Award | 1,165 | $2.4K |
| Oct 1, 2026 | Patricia B. Prichep, Chief Financial Officer | Grant/Award | 2,082 | $4.3K |
| Oct 1, 2026 | Geert R. Kersten, Chief Executive Officer | Grant/Award | 2,621 | $5.4K |
| Aug 26, 2026 | Geert R. Kersten, Chief Executive Officer | Purchase | 100,000 | $138.0K |
| Aug 17, 2026 | Robert Eugene Watson | Grant/Award | 110,000 | $1.1K |
| Aug 17, 2026 | Bruno Jean-Marie Baillavoine | Grant/Award | 110,000 | $1.1K |
| Aug 17, 2026 | John Cipriano, Senior Vice President | Grant/Award | 80,000 | $800.00 |
| Aug 17, 2026 | Eyal Talor, Chief Scientific Officer | Grant/Award | 250,000 | $2.5K |
| Aug 17, 2026 | Patricia B. Prichep, Chief Financial Officer | Grant/Award | 225,000 | $2.3K |
| Aug 17, 2026 | Geert R. Kersten, Chief Executive Officer | Grant/Award | 300,000 | $3.0K |